Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei

Sandro Pasquali, Antonio Sommariva, Haile Mahteme, Tao Suo, Huaixing Ma, Saveria Tropea, Josephine L. Steenberg, Simone Mocellin

Research output: Contribution to journalReview articlepeer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The aim of this work is to evaluate the efficacy of cytoreductive surgery alone versus cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy (HIPEC), on patient benefits, complications and short-term outcomes in patients with pseudomyxoma peritonei (PMP).

Original languageEnglish
Article numberCD005659
JournalCochrane Database of Systematic Reviews
Volume2018
Issue number9
DOIs
Publication statusPublished - Sep 6 2018

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei'. Together they form a unique fingerprint.

Cite this